The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter

被引：37

作者：

Lowe, John A., III ^{[1
]}

Hou, Xinjun ^{[1
]}

Schmidt, Christopher ^{[1
]}

Tingley, F. David, III ^{[1
]}

McHardy, Stan ^{[1
]}

Kalman, Monica ^{[1
]}

DeNinno, Shari ^{[1
]}

Sanner, Mark ^{[1
]}

Ward, Karen ^{[1
]}

Lebel, Lorraine ^{[1
]}

Tunucci, Don ^{[1
]}

Valentine, James ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Groton, CT 06340 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 11期

关键词：

Glycine; Transporter; Inhibitor; 3.1.0]-Azabicyclic; Schizophrenia; NMDA;

D O I：

10.1016/j.bmcl.2009.04.035

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The type 1 glycine transporter plays an important in regulating homeostatic glycine levels in the brain that are relevant to the activation of the NMDA receptor by the excitatory neurotransmitter glutamate. We describe herein the structure-activity relationships (SAR) of a structurally novel class of GlyT1 inhibitors following on a lead derived from high throughput screening, which shows good selectivity for GlyT1 and potent activity in elevating CSF levels of glycine. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：2974 / 2976

页数：3

共 50 条

[1] The discovery of a structurally novel class of inhibitors of the type 1glycine transporter (vol 19, pg 2974, 2009)
Lowe, John A., III
Hou, Xinjun
Schmidt, Christopher
Tingley, F. David, III
McHardy, Stan
Kalman, Monica
DeNinno, Shari
Sanner, Mark
Ward, Karen
Lebel, Lorraine
Tunucci, Don
Valentine, James
Bronk, Brian S.
Schaeffer, Eric
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (16) : 4885 - 4885
[2] Acylglycinamides as inhibitors of glycine transporter type 1
Blunt, Richard
Porter, Roderick
Johns, Amanda
Nash, David
Puckey, Gemma
Wyman, Paul
Herdon, Hugh
Teague, Simon
Hadden, Victoria
Fontana, Stefano
Gordon, Laurie
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (20) : 6176 - 6179
[3] Novel inhibitors of the type 1 transporter for glycine (GlyT1) as antipsychotic agents
Lowe, JA
EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (11) : 1657 - 1662
[4] Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain
Dohi, Toshihiro
Morita, Katsuya
Kitayama, Tomoya
Motoyama, Naoyo
Morioka, Norimitsu
PHARMACOLOGY & THERAPEUTICS, 2009, 123 (01) : 54 - 79
[5] Discovery of Novel Aminotetralines and Aminochromanes as Selective and Competitive Glycine Transporter 1 (GlyT1) Inhibitors
Amberg, Willi
Lange, Udo E. W.
Ochse, Michael
Pohlki, Frauke
Behl, Berthold
Relo, Ana Lucia
Hornberger, Wilfried
Hoft, Carolin
Mezler, Mario
Sydor, Jens
Wang, Ying
Zhao, Hongyu
Brewer, Jason T.
Dietrich, Justin
Li, Huanqiu
Akritopoulou-Zanze, Irini
Lao, Yanbin
Hannick, Steven M.
Ku, Yi-Yin
Vasudevan, Anil
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (17) : 7503 - 7524
[6] Glycine transporter type-1 and its inhibitors
Harsing, LG
Juranyi, Z
Gacsalyi, I
Tapolicsanyi, P
Czompa, A
Matyus, P
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (09) : 1017 - 1044
[7] Interactions between glycine transporter type 1 (GlyT-1) and some inhibitor molecules Glycine - transporter type 1 and its inhibitors (Review)
Harsing, L. G., Jr.
Zsilla, G.
Matyus, P.
Nagy, K. M.
Marko, B.
Gyarmati, Zs
Timar, J.
ACTA PHYSIOLOGICA HUNGARICA, 2012, 99 (01) : 1 - 17
[8] Discovery of a novel, structurally unique class agonists
Ward, KM
Hubbard, ST
Jones, SB
Nason, DM
Lee, MH
Biggers, CK
Nowakowski, J
Yohannes, D
Villalobos, A
Snider, RM
White, WF
Liston, DR
LIFE SCIENCES, 1997, 60 (13-14) : 3 - 3
[9] Discovery of the first potent and selective inhibitors of the glycine transporter type 2 and their analgesic properties.
Rankovic, Z
Caulfield, WL
Collie, IT
Dickins, RS
Epemolu, O
McGuire, R
Hill, DR
McVey, G
Morphy, JR
Sundaram, H
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A88 - A88
[10] The discovery of potent glycine transporter type-2 inhibitors: Design and synthesis of phenoxymethylbenzamide derivatives
Takahashi, Eiki
Arai, Tadamasa
Akahira, Masato
Nakajima, Mayumi
Nishimura, Kazumi
Omori, Yu
Kumagai, Hiroki
Suzuki, Tomohiko
Hayashi, Ryoji
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (18) : 4603 - 4606

← 1 2 3 4 5 →